Skip to main content

Table 1 Patient characteristics

From: Retrospective assessment of a collaborative digital asthma program for Medicaid-enrolled children in southwest Detroit: reductions in short-acting beta-agonist (SABA) medication use

Characteristic

N = 51

Age (mean (SD)), years

11.5 (2.4)

Gender, n (%)

Female

12 (23.5)

Missing

10 (19.6)

Asthma control at enrollment, (mean (SD))

Uncontrolled (ACT ≤ 19), n (%)

15 (29.4)

Controlled (ACT > 19), n (%)

20 (39.2)

Missing, n (%)

16 (31.4)

Days in program (per SABA syncing)

290.4 (185.5)

Month 1 (baseline) SABA usage data

Daily SABA use (mean (SD)), puffs/day

0.68 (1.11)

Daily SABA use (median(IQR)), puffs/day

0.27 (0.13, 0.98)

Weekly SABA use (mean (SD)), puffs/week

4.79 (7.77)

Weekly SABA use (median(IQR)), puffs/week

1.87 (0.93, 6.88)

SABA-free days (mean (SD)), days

25.2 (4.8)

SABA-free days (median(IQR)), days

27 (22.5, 29)

Number of SABA medications on hand (patient-reported)

1

32 (62.7)

2

18 (35.3)

3

1 (2.0)

Number of followers per patient, mean (SD)

3.20 (2.2)

Patients with ≥ 2 followers, n (%)

35 (68.6)

Number of patients with a compatible controller inhaler

9 (17.6)